Le Lézard
Classified in: Health
Subject: FDA

WONTECH's Holmium laser 'Holinwon Prima' Received FDA approval

SEOUL, South Korea, Sept. 6, 2019 /PRNewswire/ -- WONTECH, a leading Korean medical device company, announced that its Holmium laser device, Holinwon Prima, received U.S. Food and Drug Administration approval.

WONTECH's Holmium Laser, Holinwon Prima

Holinwon Prima, approved by the FDA, is the first Holmium laser medical device developed in Korea.

It's able to perform various operations such as BPH (Benign Prostate Hyperplasia), endoscopic laser surgery for spinal diseases such as HNP (Herniated Necleus Purposus) and removal of urinary stone (bladder stone, ureter stone, kidney stone).

Holmium lasers, 2,100nm wavelengths of Holinwon Prima, have water-absorbing properties, so the damage caused by heat is very low and the depth of tissue penetration is only 0.44mm.

When tissue is dissected, detailed and sophisticated laser surgery is possible while minimizing damage to surrounding tissues.

Seung-woo Song, Chief of the U.S branch of WONTECH said, "We were delighted to receive FDA approval for the first time in Korea with the effectiveness and stability of WONTECH's holmium laser device. We'll make efforts to maintain constant technical innovation and will continuously improve healthcare division, which are medical devices for surgery based on our own technology."

In addition, WONTECH received a lot of attention from joint- development of the Holinwon series called "Holinwon Pro" with Prof. Seung-jun Oh of Seoul National University Hospital (SNUH), a global top authority on Ho:LEP surgery.

About WONTECH Co., Ltd.

WOWONTECH is a rapidly growing company in the world of laser and energy-based medical devices. Established in 1999 as WONTECH Co., Ltd., the company has a diverse product lineup of 50 kinds of lasers, ultrasound, and radio frequency products based on laser medical device technology. In recent years, WONTECH has been broadening its focus to B2C businesses and surgical fields. WONTECH is a company specialized in medical devices that is exporting products to as many as 60 countries around the world, with accumulated technology associated with 180s intellectual property rights. For more information, please visit www.wtlaser.com.


These press releases may also interest you

at 17:50
Amphivena Therapeutics, Inc., a private clinical stage immuno-oncology company developing T cell engager therapeutics for cancer, presented today at the American Society of Hematology annual meeting data from a Phase 1 study of its bivalent T cell...

at 17:40
Welltower Inc. announces that on December 24, 2019, it is redeeming all of the outstanding 3.35% Senior Notes due November 25, 2020 (the "Notes") issued by HCN Canadian Holdings-1 LP, its wholly-owned subsidiary, in accordance with the terms of the...

at 17:20
Quest Diagnostics Incorporated , the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $800 million aggregate principal amount of its 2.950% senior notes due 2030 under the Quest...

at 17:20
Bariatric Surgery Devices (General Surgery) - Global Market Analysis and Forecast Model Read the full report: https://www.reportlinker.com/p05830908/?utm_source=PRN Summary Bariatric Surgery Devices (General Surgery) - Global Market Analysis and...

at 17:19
Florida International University Distinguished Professor Madhavan Nair has been named a Fellow of the National Academy of Inventors (NAI). Nair, an internationally renowned expert in nanotechnology and HIV research, is the founding chair of the...

at 17:05
TFF Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced its third quarter 2019...

News published on 6 september 2019 at 06:36 and distributed by: